Results typically improve when combined with lifestyle changes such as a healthy diet and regular physical activity
Approved for adults with a BMI of 30 or more, or 27 or higher with comorbidities, Wegovy has shown to help participants lose an average of 15% of their body weight over 68 weeks
Official guidelines on missed doses (from Novo Nordisk) Novo Nordisk recommends the following for missed doses: If its been less than 2 days (48 hours) since your missed dose: Take the missed dose as soon as you remember
If you see white specks or particles in your medication, do not inject it
These medications work in the brain, in the hypothalamus, to directly reduce appetite and cravings. There are several medications currently on the market that use semaglutide as their main ingredient, including: Presently, Wegovy is the only semaglutide medication FDA-approved for both weight loss and cardiovascular risk reduction
Diabetic Retinopathy Complications Rapid blood glucose improvement particularly with semaglutide has been associated with temporary worsening of diabetic retinopathy in patients who already have this condition
